Literature DB >> 791743

Extrahepatic malignancy in chronic liver disease: report of six cases.

A Viteri, S J Vernace, F Schaffner.   

Abstract

Six patients are described with chronic liver disease, 3 with primary biliary cirrhosis and 3 with chronic active hepatitis, all of whom developed malignant disease in organs other than the liver. Two malignancies were mixed histiocytic-lymphocytic lymphomas. All patients had received corticosteroid or azathioprine therapy. Specific lymphocyte counts and immunoglobulin and antibody determinations failed to reveal a consistent pattern of abnormality to recognize the patient at risk. Several diseases in which the immune responsiveness is disturbed seem to have this potentiality in common, especially if therapy that further alters immunological reactivity is given.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 791743

Source DB:  PubMed          Journal:  Gastroenterology        ISSN: 0016-5085            Impact factor:   22.682


  5 in total

1.  Extrahepatic malignancy.

Authors:  R Natangelo; A Monarca; E Tavani; L Adelasco; G Croce
Journal:  Dig Dis Sci       Date:  1984-06       Impact factor: 3.199

2.  Development of Hodgkin's disease in the course of liver cirrhosis and impaired monocyte function.

Authors:  M Dan; A Hassner; M Jedwab; S Shibolet
Journal:  Postgrad Med J       Date:  1984-07       Impact factor: 2.401

3.  Primary biliary cirrhosis: an increased incidence of extrahepatic malignancies?

Authors:  P R Mills; P Boyle; E M Quigley; G G Birnie; F Jarrett; G Watkinson; R N MacSween
Journal:  J Clin Pathol       Date:  1982-05       Impact factor: 3.411

4.  Malignant lymphoproliferative disorders in chronic liver disease. Report of four cases and review of the literature.

Authors:  J Naparstek; M Eliakim
Journal:  Am J Dig Dis       Date:  1978-10

5.  Hepatocellular carcinoma complicating chronic granulomatous hepatitis.

Authors:  W M Melia; H Calvey; B Portmann; R Williams
Journal:  J Clin Pathol       Date:  1983-09       Impact factor: 3.411

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.